xIPOmeter
IntraBio
IntraBio is a leading biopharmaceutical company that works on new treatments for rare and brain-related diseases. The company is built on the expertise of its founders from the University of Oxford and the University of Munich, focusing on diseases that currently have few or no treatments. IntraBio's research is advanced and aims at improving treatments for various neurological and aging-related conditions. Their work involves cutting-edge science in areas like genetics and brain health, with the goal of developing effective medications for these challenging diseases.
NewsHeat chart
- Week
- Month
- Year
- Media news
- Corp news
The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice
Company Valuation
- Valuation
- Share Price
- Cumulative Funding
The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.
*** - To view the data, please log into your account or create a new one.
News related to IntraBio5
IntraBioCurant Health Selected By IntraBio as the Exclusive Specialty ...
This groundbreaking therapy is the first FDA-approved stand-alone treatment for Niemann-Pick Disease Type C (NPC), a rare genetic disorder. ADVERTISEMENT....
https://finance.yahoo.com/news/curant-health-selected-intrabio-exclusive-133000400.htmlIntraBioUS FDA approves IntraBio's drug for rare genetic disease
(Reuters) -The U.S. Food and Drug Administration approved IntraBio's drug for a rare and fatal genetic disorder, the health regulator said on Tuesday, ...
https://www.msn.com/en-us/health/other/us-fda-approves-intrabios-drug-for-rare-genetic-disease/ar-AA1r90QN?ocid=BingNewsVerpIntraBioIntraBio Announces U.S. FDA Approval of AQNEURSA for the ...
AUSTIN, Texas, September 25, 2024--IntraBio Inc., a leader in the discovery and development of innovative drugs for rare neurodegenerative diseases, ...
https://finance.yahoo.com/news/intrabio-announces-u-fda-approval-120000760.htmlIntraBioUS FDA approves IntraBio's drug for rare genetic disease | Reuters
Sept 24(Reuters) - The U.S. Food and Drug Administration approved IntraBio's drug for a rare and fatal genetic disorder, the health regulator said on ...
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-intrabios-drug-rare-genetic-disease-2024-09-24/IntraBioUK biopharma company IntraBio moves HQ to Austin, raises $40M
U.K.-based IntraBio is moving its HQ to the city. ...
https://www.bizjournals.com/austin/news/2024/03/26/uk-biopharma-intrabio-hq-austin.html